Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 157,225 ordinary shares between September 28th and October 2nd, 2026, with an aggregated volume-weighted average price of approximately 841.75 pence per share, and intends to cancel these shares. The transactions were executed through its broker, Investec Bank plc, under the authority granted by shareholders at the 2025 Annual General Meeting.

Disclaimer*

Fevertree Drinks PLC
06 October 2026
 

6th October 2026  

Fevertree Drinks plc

(“Fever-Tree” or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc (“Fever-Tree” or the “Company”) announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the “Ordinary Shares”) through the Company’s broker, Investec Bank plc (“Investec”) in the period from 28th September to 2nd October 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

28 September 2026

XLON

837.7658

25,678

830.0000

847.0000

28 September 2026

AIMX

830.0000

13,407

830.0000

830.0000

29 September 2026

XLON

840.4024

20,480

817.0000

848.0000

30 September 2026

XLON

858.7812

27,421

851.0000

863.0000

30 September 2026

AIMX

853.5000

11,086

853.5000

853.5000

01 October 2026

XLON

838.9216

20,379

831.0000

846.5000

01 October 2026

AIMX

835.0000

17,788

835.0000

835.0000

02 October 2026

XLON

841.5741

15,646

829.0000

858.0000

02 October 2026

AIMX

843.7500

15,000

843.7500

843.7500

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases – Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/6177X_1-2026-10-5.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 7435 828 138

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings